It’s a small trial in one academic institution, one site. it’s more of a proof of concept trial than one intended for marketing approval. I would not be surprised that this trial morphs into a true combo trial with DCVax/Keytruda now that the data is out, increasing to other institutions/sites. Remember, Dr. Liau did a small trial of her vaccine on only 2 patients in the early 2000’s and NWBO came in, copyrighted the name, improved the process and started a larger trial with Dr. Liau as the principal investigator.